Nicholson Wealth Management Group LLC Buys 4,596 Shares of Zoetis Inc. $ZTS

Nicholson Wealth Management Group LLC raised its holdings in Zoetis Inc. (NYSE:ZTS) by 45.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 14,654 shares of the company’s stock after purchasing an additional 4,596 shares during the quarter. Nicholson Wealth Management Group LLC’s holdings in Zoetis were worth $1,844,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of ZTS. Diamond Hill Capital Management Inc. bought a new position in Zoetis in the 3rd quarter valued at $394,010,000. Nordea Investment Management AB raised its position in Zoetis by 79.2% in the 4th quarter. Nordea Investment Management AB now owns 4,932,787 shares of the company’s stock valued at $622,222,000 after purchasing an additional 2,179,578 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in Zoetis by 83.4% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,697,827 shares of the company’s stock valued at $394,746,000 after purchasing an additional 1,227,085 shares during the last quarter. Corient Private Wealth LLC raised its position in Zoetis by 85.9% in the 2nd quarter. Corient Private Wealth LLC now owns 2,578,593 shares of the company’s stock valued at $400,619,000 after purchasing an additional 1,191,840 shares during the last quarter. Finally, First Trust Advisors LP raised its position in Zoetis by 342.1% in the 3rd quarter. First Trust Advisors LP now owns 1,485,459 shares of the company’s stock valued at $217,352,000 after purchasing an additional 1,149,467 shares during the last quarter. Institutional investors own 92.80% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on the company. BTIG Research reiterated a “buy” rating and issued a $160.00 price objective on shares of Zoetis in a research report on Thursday, February 26th. Wall Street Zen upgraded Zoetis from a “hold” rating to a “buy” rating in a research report on Saturday, February 21st. Citigroup assumed coverage on Zoetis in a research report on Wednesday. They issued a “buy” rating and a $145.00 price objective for the company. Bank of America lifted their price objective on Zoetis from $135.00 to $140.00 and gave the company a “neutral” rating in a research report on Friday, February 13th. Finally, Leerink Partners reiterated a “market perform” rating on shares of Zoetis in a research report on Tuesday, March 10th. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $152.25.

Zoetis Stock Down 0.2%

NYSE ZTS opened at $120.81 on Thursday. The stock has a fifty day moving average of $121.98 and a 200-day moving average of $126.70. The stock has a market capitalization of $50.82 billion, a P/E ratio of 20.07, a price-to-earnings-growth ratio of 1.85 and a beta of 0.98. Zoetis Inc. has a 52 week low of $113.29 and a 52 week high of $172.23. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.94 and a current ratio of 3.03.

Zoetis (NYSE:ZTS) last released its earnings results on Thursday, February 12th. The company reported $1.48 EPS for the quarter, beating the consensus estimate of $1.40 by $0.08. The company had revenue of $2.39 billion during the quarter, compared to analysts’ expectations of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The business’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same period last year, the firm earned $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, equities research analysts forecast that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Monday, April 20th. Zoetis’s dividend payout ratio (DPR) is 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.